意见反馈 手机随时随地看行情
  • 公司公告

公司公告

安道麦B:独立董事对第九届董事会第十八次会议相关事项的事前认可意见(英文版)2023-02-16  

                                                        ADAMA Ltd.

   Pre-approval of the Independent Directors on the
Relevant Matters of the 18th Meeting of the 9th Session
                        of the Board of Directors

In accordance with the Company Law of the People’s Republic of China, Rules for
Independent Directors of Listed Companies, and other laws, regulations and
normative documents, as well as the Articles of Association and Independent Director
System, we, as the independent directors of ADAMA Ltd. (hereinafter referred to as
“Company”), had a prior review on the relevant matters of the 18th meeting of the 9th
session of the Board of Directors. We give our opinions from the standpoint of
independent judgment:

1. Pre-approval on Credit Facilities from the Related Party

The Company's wholly-owned subsidiary, Adama Agricultural Solutions Ltd.
("Solutions") (directly, or through one or more of its subsidiaries) is contemplating
applying for new credit facilities not exceeding USD 250 million from any of the
overseas subsidiaries of Syngenta Group Co., Ltd., which is reasonable and sufficient
for expanding the funding sources of the Company and its subsidiaries and is normal
business operations.

The transactions are based on the principles of voluntariness, fairness and
reasonableness. The transactions price and method meet market terms. The
transactions will not harm the interests of the Company, the non-related shareholders,
and the medium-small shareholders.

We pre-approve the above matter on the related party transaction and agree to submit
the matter to the Board of Directors.


                                           1
(The signature page of Pre-approval of the Independent Directors on the Relevant
Matters of the 18th Meeting of the 9th Session of the Board of Directors)




Independent Director Signature:




__________________                              ___________________

    Ge Ming                                            Xi Zhen




                                                             February 14, 2023




                                       2